be real big. In addition
it maybe useful in a number of other disease indications.
It seems they have best and brightest and they have the finances though I don't know how much Port gages interest was diluted from the 48 percent stake they already ha
d unless Boi havens capital structure has two classes of stock. Voting for the original equity owners in the original class A financing and non voting
in another class of stock.
If the two phase 3 trials they initiated hits
one or the other or even one with a zero chance,a 50 percent chance a 100 percent chance to be sucessful.The stock price will stay where it is at present price, double in price for one sucessful.It trial ,triple in price or blue sky if both trials are successful.Any other info or thoughts are appreciated
Recent PRTG News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/15/2024 12:31:46 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/15/2024 12:00:08 PM
- Portage Biotech Reports Fiscal Year-Ended March 31, 2024 Financial Results and Business Update • GlobeNewswire Inc. • 08/15/2024 11:00:00 AM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 09:29:07 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/13/2024 12:52:42 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/13/2024 12:00:25 PM
- Portage Biotech Announces 1-for-20 Reverse Stock Split • GlobeNewswire Inc. • 08/13/2024 11:00:00 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/01/2024 08:31:28 PM
- Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives • GlobeNewswire Inc. • 04/12/2024 12:01:00 PM
- Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares • GlobeNewswire Inc. • 03/26/2024 12:01:13 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/08/2024 10:30:43 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/08/2024 10:04:30 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/28/2024 10:19:51 PM
- Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business Update • GlobeNewswire Inc. • 02/28/2024 10:10:19 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:50:16 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/18/2024 10:09:11 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/04/2024 01:10:06 PM
- Portage Biotech Reports Business and Strategic Update • GlobeNewswire Inc. • 01/04/2024 01:00:37 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 12/01/2023 09:05:45 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/28/2023 09:03:19 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/28/2023 09:02:08 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/28/2023 09:01:24 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/14/2023 11:00:29 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/13/2023 11:10:09 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/08/2023 05:15:28 AM
FEATURED Mawson Finland Provides Update on Exploration Activities at Rajapalot • Aug 21, 2024 9:06 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM
Avant Technologies to Implement Robust Cybersecurity Measures for AI-Driven Healthcare Solutions • AVAI • Aug 21, 2024 8:00 AM
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM